First Insulin Pen with No Push-Button Extension Now Available

First Insulin Pen with No Push-Button Extension Now Available
First Insulin Pen with No Push-Button Extension Now Available
Novo Nordisk announced the availability of the Levemir (insulin detemir [rDNA origin] injection) FlexTouch, a new prefilled insulin delivery device.

Novo Nordisk announced the availability of the Levemir (insulin detemir [rDNA origin] injection) FlexTouch, a new prefilled insulin delivery device.

When a dose is dialed with traditional prefilled pens, the push button extends and at larger doses can present challenges for the patient. Levemir FlexTouch is the first prefilled insulin delivery device with no push-button extension and allows insulin to be administered by pressing the low dose force button.

RELATED: Insulin Pen Devices Chart

Levemir FlexTouch is a prefilled insulin pen that contains 300 units of insulin detemir (long-acting) that doses in 1-unit increments, from 1–80 units. It is compatible with both NovoFine and NovoTwist needles. Levemir is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

For more information call (800) 727-6500 or visit NovoNordisk-US.com.